{"id":852805,"date":"2025-05-20T09:04:01","date_gmt":"2025-05-20T13:04:01","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\/"},"modified":"2025-05-20T09:04:01","modified_gmt":"2025-05-20T13:04:01","slug":"cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\/","title":{"rendered":"CBIZ Report Highlights Rising Costs: Surge in Inpatient and Outpatient Expenses, Popular GLP-1 Drugs like Ozempic Drive Pharmacy Spend Increase"},"content":{"rendered":"<p>        <!--.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p><b>CBIZ Report Highlights Rising Costs: Surge in Inpatient and Outpatient Expenses, Popular GLP-1 Drugs like Ozempic Drive Pharmacy Spend Increase<\/b><\/p>\n<p><b><i>New CBIZ State of Healthcare Report Reveals Cost Increases, Significant Impact of GLP-1 Drugs on Pharmacy Spend, and Regulatory Changes Expanding Employee Protections and Accessibility<\/i><\/b><\/p>\n<p>CLEVELAND&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nCBIZ, Inc. (NYSE: CBZ), a leading national professional services advisor, announced the release of its <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww2.cbiz.com%2F2025StateofHealthcareReport%3Futm_source%3Dcbiz_ir%26utm_medium%3Dpress_release%26utm_campaign%3Deb_sohc%26utm_content%3Demployee_benefits%26utm_term%3D5152025&amp;esheet=54257302&amp;newsitemid=20250520808811&amp;lan=en-US&amp;anchor=2025+State+of+Healthcare+Report&amp;index=1&amp;md5=2fba7a937299f1804a5eadfa9ed995c5\">2025 State of Healthcare Report<\/a><i>. <\/i>The report provides a data-driven look at trends affecting employer-sponsored healthcare and the strategies organizations are using to stay competitive.\n<\/p>\n<p>\nNow, more than ever, employers face increased pressure to balance affordability with employee wellbeing as healthcare costs continue to rise. The State of Healthcare Report draws on CBIZ\u2019s proprietary data from more than 290,000 plan members, delivering insights into care delivery, cost containment, and regulatory compliance.\n<\/p>\n<p>\nKey insights from the report:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nHealthcare costs continue to rise, with CBIZ data finding that cost per visit for inpatient, outpatient, and professional care increased from 2022 to 2024.\n<\/li>\n<li>\nCBIZ data shows that GLP-1s are a significant cost driver in employers\u2019 pharmacy spend. GLP-1 spend as a percentage of overall pharmacy spend has increased from 9% in 2022 to 17% in 2024. This trend is expected to continue as these medications grow in popularity.\n<\/li>\n<li>\nOngoing regulatory changes, specifically those occurring at the state level, are shifting employer-sponsored healthcare. Many of these regulations expand protections and accessibility for employees, and employers must continue to monitor relevant legislation to maintain compliance.\n<\/li>\n<\/ul>\n<p>\n\u201cHealthcare has never been more complex than it is right now,\u201d said Cole Harris, Business Unit President, National Practice Leader for Health Innovations. \u201cThe report is designed to give employers real data-driven insights and forward-looking guidance to navigate our increasingly complex environment.\u201d\n<\/p>\n<p>\nThe State of Healthcare Report provides a high-level overview of emerging risks and opportunities, featuring analysis from our experts on how to proactively tackle these challenges through data, innovation, and smarter benefits design.\n<\/p>\n<p>\nTo download the full report, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww2.cbiz.com%2F2025StateofHealthcareReport%3Futm_source%3Dcbiz_ir%26utm_medium%3Dpress_release%26utm_campaign%3Deb_sohc%26utm_content%3Demployee_benefits%26utm_term%3D5152025&amp;esheet=54257302&amp;newsitemid=20250520808811&amp;lan=en-US&amp;anchor=2025+State+of+Healthcare+Report&amp;index=2&amp;md5=3a480f6d445c2fc72674b37fa8d7a493\">2025 State of Healthcare Report<\/a><\/p>\n<p><b>About CBIZ<\/b><\/p>\n<p>\nCBIZ, Inc. (NYSE: CBZ) is a leading professional services advisor to middle market businesses and organizations nationwide. With unmatched industry knowledge and expertise in accounting, tax, advisory, benefits, insurance, and technology, CBIZ delivers forward-thinking insights and actionable solutions to help clients anticipate what&#8217;s next and discover new ways to accelerate growth. CBIZ has more than 10,000 team members across more than 160 locations in 22 major markets coast to coast. For more information, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.cbiz.com&amp;esheet=54257302&amp;newsitemid=20250520808811&amp;lan=en-US&amp;anchor=www.cbiz.com&amp;index=3&amp;md5=aca7a4cebebc07e5e66a7b5b4cd2e3cb\">www.cbiz.com<\/a>.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250520808811r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20250520808811\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20250520808811\/en\/<\/a><\/span><\/p>\n<p><b>Media:<\/b> Amy McGahan, Director of Corporate &amp; Strategic Communications, <a rel=\"nofollow\" href=\"mailto:amy.mcgahan@cbiz.com\">amy.mcgahan@cbiz.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America Ohio<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Other Professional Services Insurance Data Analytics General Health Health Professional Services Health Insurance Other Health<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250520808811\/en\/2474495\/3\/CBIZ_logo_2023.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>CBIZ Report Highlights Rising Costs: Surge in Inpatient and Outpatient Expenses, Popular GLP-1 Drugs like Ozempic Drive Pharmacy Spend Increase New CBIZ State of Healthcare Report Reveals Cost Increases, Significant Impact of GLP-1 Drugs on Pharmacy Spend, and Regulatory Changes Expanding Employee Protections and Accessibility CLEVELAND&#8211;(BUSINESS WIRE)&#8211; CBIZ, Inc. (NYSE: CBZ), a leading national professional services advisor, announced the release of its 2025 State of Healthcare Report. The report provides a data-driven look at trends affecting employer-sponsored healthcare and the strategies organizations are using to stay competitive. Now, more than ever, employers face increased pressure to balance affordability with employee wellbeing as healthcare costs continue to rise. The State of Healthcare Report draws on CBIZ\u2019s proprietary data from more than &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;CBIZ Report Highlights Rising Costs: Surge in Inpatient and Outpatient Expenses, Popular GLP-1 Drugs like Ozempic Drive Pharmacy Spend Increase&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-852805","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CBIZ Report Highlights Rising Costs: Surge in Inpatient and Outpatient Expenses, Popular GLP-1 Drugs like Ozempic Drive Pharmacy Spend Increase - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CBIZ Report Highlights Rising Costs: Surge in Inpatient and Outpatient Expenses, Popular GLP-1 Drugs like Ozempic Drive Pharmacy Spend Increase - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CBIZ Report Highlights Rising Costs: Surge in Inpatient and Outpatient Expenses, Popular GLP-1 Drugs like Ozempic Drive Pharmacy Spend Increase New CBIZ State of Healthcare Report Reveals Cost Increases, Significant Impact of GLP-1 Drugs on Pharmacy Spend, and Regulatory Changes Expanding Employee Protections and Accessibility CLEVELAND&#8211;(BUSINESS WIRE)&#8211; CBIZ, Inc. (NYSE: CBZ), a leading national professional services advisor, announced the release of its 2025 State of Healthcare Report. The report provides a data-driven look at trends affecting employer-sponsored healthcare and the strategies organizations are using to stay competitive. Now, more than ever, employers face increased pressure to balance affordability with employee wellbeing as healthcare costs continue to rise. The State of Healthcare Report draws on CBIZ\u2019s proprietary data from more than &hellip; Continue reading &quot;CBIZ Report Highlights Rising Costs: Surge in Inpatient and Outpatient Expenses, Popular GLP-1 Drugs like Ozempic Drive Pharmacy Spend Increase&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-20T13:04:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250520808811r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"CBIZ Report Highlights Rising Costs: Surge in Inpatient and Outpatient Expenses, Popular GLP-1 Drugs like Ozempic Drive Pharmacy Spend Increase\",\"datePublished\":\"2025-05-20T13:04:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\\\/\"},\"wordCount\":470,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250520808811r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\\\/\",\"name\":\"CBIZ Report Highlights Rising Costs: Surge in Inpatient and Outpatient Expenses, Popular GLP-1 Drugs like Ozempic Drive Pharmacy Spend Increase - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250520808811r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2025-05-20T13:04:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250520808811r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250520808811r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CBIZ Report Highlights Rising Costs: Surge in Inpatient and Outpatient Expenses, Popular GLP-1 Drugs like Ozempic Drive Pharmacy Spend Increase\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CBIZ Report Highlights Rising Costs: Surge in Inpatient and Outpatient Expenses, Popular GLP-1 Drugs like Ozempic Drive Pharmacy Spend Increase - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\/","og_locale":"en_US","og_type":"article","og_title":"CBIZ Report Highlights Rising Costs: Surge in Inpatient and Outpatient Expenses, Popular GLP-1 Drugs like Ozempic Drive Pharmacy Spend Increase - Market Newsdesk","og_description":"CBIZ Report Highlights Rising Costs: Surge in Inpatient and Outpatient Expenses, Popular GLP-1 Drugs like Ozempic Drive Pharmacy Spend Increase New CBIZ State of Healthcare Report Reveals Cost Increases, Significant Impact of GLP-1 Drugs on Pharmacy Spend, and Regulatory Changes Expanding Employee Protections and Accessibility CLEVELAND&#8211;(BUSINESS WIRE)&#8211; CBIZ, Inc. (NYSE: CBZ), a leading national professional services advisor, announced the release of its 2025 State of Healthcare Report. The report provides a data-driven look at trends affecting employer-sponsored healthcare and the strategies organizations are using to stay competitive. Now, more than ever, employers face increased pressure to balance affordability with employee wellbeing as healthcare costs continue to rise. The State of Healthcare Report draws on CBIZ\u2019s proprietary data from more than &hellip; Continue reading \"CBIZ Report Highlights Rising Costs: Surge in Inpatient and Outpatient Expenses, Popular GLP-1 Drugs like Ozempic Drive Pharmacy Spend Increase\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\/","og_site_name":"Market Newsdesk","article_published_time":"2025-05-20T13:04:01+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250520808811r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"CBIZ Report Highlights Rising Costs: Surge in Inpatient and Outpatient Expenses, Popular GLP-1 Drugs like Ozempic Drive Pharmacy Spend Increase","datePublished":"2025-05-20T13:04:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\/"},"wordCount":470,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250520808811r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\/","name":"CBIZ Report Highlights Rising Costs: Surge in Inpatient and Outpatient Expenses, Popular GLP-1 Drugs like Ozempic Drive Pharmacy Spend Increase - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250520808811r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2025-05-20T13:04:01+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250520808811r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250520808811r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cbiz-report-highlights-rising-costs-surge-in-inpatient-and-outpatient-expenses-popular-glp-1-drugs-like-ozempic-drive-pharmacy-spend-increase\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"CBIZ Report Highlights Rising Costs: Surge in Inpatient and Outpatient Expenses, Popular GLP-1 Drugs like Ozempic Drive Pharmacy Spend Increase"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/852805","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=852805"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/852805\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=852805"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=852805"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=852805"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}